Thromboangiitis obliterans (TAO) is often diagnosed late and characterized by high amputation rates. TAO-specific early diagnostic and disease-staging biomarkers are urgently needed. A staged mass ...

Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of Parkinson's disease and a way to modify it, paving the way for future ...

In this edition of In the Mood, our experts explain what Peyronie’s disease is and how to prevent it from ruining intimacy with your partner.

Health Why Lyme disease and other tick-borne conditions are on the rise Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

Erin Moriarty is getting candid about her health — and urging fans to listen to their bodies. The Boys star, 30, revealed on Instagram Thursday that she was diagnosed with Graves’ disease last ...

Health and Human Services Secretary Robert F. Kennedy Jr. has tapped eight new members to join the Centers for Disease Control and Prevention’s independent vaccine advisory committee, just two ...

A new AI tool to predict the spread of infectious disease outperforms existing state-of-the-art forecasting methods. The tool, created with federal support by researchers at Johns Hopkins and Duke ...

U.S. and state officials say the consolidation of the public health agency’s vast trove of information could expose patients and will delay analysis of long-term trends.

Great star corals in the grip of disease have been saved with probiotics — beneficial bacteria that attack or displace invading pathogens or possibly trigger immune responses to them. What’s ...

HHS plans to fold the CDC's chronic disease center into the new Administration for a Healthy America. Experts fear for coordination with local health departments, among other things.

Morten Harket, the lead singer of the Norwegian synth-pop band a-ha, best known for its 1985 hit single “Take on Me,” said Wednesday that he had Parkinson’s disease.

This dual inhibition may be able to reduce both multiple sclerosis disease activity and disability progression, thereby potentially addressing the key unmet medical need of disability progression ...